APOE and metabolic dysfunction-associated steatotic liver disease: Gariani et al. (Gariani et al., 2016) confirmed that ApoE−/− mice with nonalcoholic fatty liver disease (NAFLD) could increase NAD+ level, reduce body weight and transaminase activities, and alleviate steatosis after NR intervention.